Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms (PEDVU)

King's College Hospital NHS Trust

Status: Active, not recruiting

Conditions: Stroke; Intracranial Hemorrhages; Brain Aneurysm

Treatments: Device: Pipeline Embolization Device with Vantage Technology

Study type: Observational

Funder types: Other

Identifiers

NCT05626504

317314

Details and patient eligibility

About

In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients treated with Pipeline Embolization Device with Vantage Technology (PEDV)
• MRA and/or DSA (or tomographic angiography) available for follow up

Exclusion criteria

• Insufficient background data available e.g., to determine size of aneurysm and pipeline device
• PEDV used for causes other than aneurysms, e.g., fistulas and dissection.